首页> 外文期刊>Frontiers in Bioengineering and Biotechnology >Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis
【24h】

Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis

机译:产生一氧化氮的心血管支架,用于预防血栓形成和再狭窄

获取原文
       

摘要

Cardiovascular stenting is an effective method for treating cardiovascular diseases (CVDs), yet thrombosis and restenosis are the two major clinical complications which often lead to device failure.Nitric oxide (NO) has been proposed as a promising small molecule in improving the clinical performance of cardiovascular stents thanks to its anti-thrombosis and anti-restenosis ability, but its short half-life limits the full use of NO. To produce NO at lesion site with sufficient amount, NO producing coatings (including NO releasing and NO generating coatings) are fashioned. Its releasing strategy is achieved by introducing exogenous NO storage materials like NO donors, while the generating strategy utilizes the in vivo substances like S-nitrosothiols (RSNOs) to generate NO flux.NO producing stents are particularly promising in future clinical use due to their ability to store NO resources or to generate large NO flux in a controlled and efficient manner. In this review, we first introduce NO releasing and generating coatings for prevention of thrombosis and restenosis. We then discuss the advantages and drawbacks on releasing and generating aspects, where possible 2 further developments are suggested.
机译:心血管支架是治疗心血管疾病(CVDS)的有效方法,但血栓形成和再狭窄是通常导致装置衰竭的两种主要临床并发症。已经提出了提高临床表现的有前途的小分子的氧化物(NO)。心血管支架由于其抗血栓形成和反再狭窄能力,但其短的半衰期限制了不含NO的充分利用。为了在具有足够量的病变部位产生的缺损,没有制造涂料(包括不释放和没有产生涂层)。其释放策略是通过引入外源没有储存材料的释放策略,而产生策略利用S-亚硝素(RSNOS)这样的体内物质以产生不产生助熔剂。由于其能力,未来临床使用尤其有望不提供资源或以受控和有效的方式生成大的磁通量。在这篇综述中,我们首先介绍不释放和产生用于预防血栓形成和再狭窄的涂料。然后,我们讨论了释放和发电方面的优点和缺点,在可能有2个进一步的进一步发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号